A single center study investigating ciclosporine A microemulsion in combination with basiliximab and prednisolone and switch to low-dose ciclosporine A and everolimus without steroids in the prevention of transplant nephropathy in pediatric renal allografts recipients.
Phase of Trial: Phase III
Latest Information Update: 22 Jun 2011
At a glance
- Drugs Ciclosporin; Everolimus
- Indications Renal transplant rejection
- Focus Adverse reactions
- 22 Jun 2011 New trial record